Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, will be taking part in the 26th European Meeting on Hypertension and Cardiovascular Protection, from the 10th to the 13th of June 2016, organised by the ESH (European Society of Hypertension), which will be held this year in France, at the Palais des Congrès de Paris.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2016/05/QUANTUM_PR_Symposium-ESH_20160531_EN-VDEF.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]
